{"TopicDetails": {"type": 0, "ccm2Id": 31069761, "cftId": 0, "identifier": "IMI2-2015-05-03", "title": "Inflammation and AD: modulating microglia function \u2013 focussing on TREM2 and CD33", "publicationDateLong": 1436400000000, "callIdentifier": "H2020-JTI-IMI2-2015-05-two-stage", "callTitle": "H2020-JTI-IMI2-2015-05-two-stage", "callccm2Id": 31069647, "frameworkProgramme": {"id": 31045243, "abbreviation": "H2020", "description": "Horizon 2020"}, "programmeDivision": [{"id": 31047894, "abbreviation": "EU.3.1.", "description": "Health, demographic change and wellbeing"}, {"id": 31062059, "abbreviation": "EU.3.1.7.", "description": "Innovative Medicines Initiative 2 (IMI2)"}, {"id": 31045244, "abbreviation": "EC", "description": "EC Treaty"}, {"id": 31047893, "abbreviation": "EU.3.", "description": "Societal Challenges"}], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": ["IMI2-RIA Research and Innovation action"], "plannedOpeningDate": "09 July 2015", "submissionProcedure": {"id": 31094505, "abbreviation": "two-stage", "description": "two-stage"}, "deadlineDates": ["13 October 2015", "15 March 2016"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3201028": [{"action": "IMI2-2015-05-03 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "09 July 2015", "deadlineModel": "two-stage", "deadlineDates": ["13 October 2015", "15 March 2016"], "budgetYearMap": {"2015": 8600000}, "budgetTopicActionMap": {}}], "3201029": [{"action": "IMI2-2015-05-04 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "09 July 2015", "deadlineModel": "two-stage", "deadlineDates": ["13 October 2015", "15 March 2016"], "budgetYearMap": {"2015": 12000000}, "budgetTopicActionMap": {}}], "3201030": [{"action": "IMI2-2015-05-01 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "09 July 2015", "deadlineModel": "two-stage", "deadlineDates": ["13 October 2015", "15 March 2016"], "budgetYearMap": {"2015": 5600000}, "budgetTopicActionMap": {}}], "3201031": [{"action": "IMI2-2015-05-06 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "09 July 2015", "deadlineModel": "two-stage", "deadlineDates": ["13 October 2015", "15 March 2016"], "budgetYearMap": {"2015": 2640000}, "budgetTopicActionMap": {}}], "3201032": [{"action": "IMI2-2015-05-02 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "09 July 2015", "deadlineModel": "two-stage", "deadlineDates": ["13 October 2015", "15 March 2016"], "budgetYearMap": {"2015": 14900000}, "budgetTopicActionMap": {}}], "3201033": [{"action": "IMI2-2015-05-05 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "09 July 2015", "deadlineModel": "two-stage", "deadlineDates": ["13 October 2015", "15 March 2016"], "budgetYearMap": {"2015": 2043000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2015"]}, "description": "<SPAN class=\"topicdescriptionkind\">Specific Challenge</SPAN>:<p>Multiple Genome-wide Association Studies and integrated systems biology approaches have linked genes involved in modulating and executing microglia mediated inflammation to Alzheimer\u2019s Disease (AD). However the role of microglia-mediated molecular pathways and the ultimate causative link between inflammation or microglia activity and AD is still an under-explored area of research.</p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>To identify druggable points of interaction in the TREM2 and CD33-signalling pathways to modulate microglial/macrophage function for the treatment of AD, focusing on in vitro, in vivo methodologies using comprehensive analysis tools and pathway/systems biology approaches to understand the role of these regulators of microglia function in AD.</p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>Resolving the role that AD risk genes such as TREM2 and CD33 play in modulating microglial function will be a critical step for understanding the controversial role of inflammation in AD. It will also pave the way to target these genes, or associated pathways, as potential AD disease modifying treatments.</p>\n", "conditions": "<p>Please read carefully all provisions below before the preparation of your application.</p>\r\n<p><em>The <strong><span style=\"color: #003366\">budget breakdown </span></strong>for this call is given iat the end of the Call topics text n the <strong><a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_fiches/jtis/h2020-call-fiche15-5-imi2-ju_en.pdf\">Call Conditions</a></strong> section,&nbsp;as well as the following information:</em></p>\r\n<ol>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">List of countries and applicable rules for funding</span></strong><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Eligibility and admissibility conditions</span></strong><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Evaluation</span></strong><strong><span style=\"color: rgb(0,51,102)\">&nbsp;criteria and procedure, scoring and threshold:</span></strong> described in <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-imi-ju_en.pdf\"><strong>IMI2</strong> Manual for submission, evaluation and grant award</a><br />\r\n    &nbsp;</li>\r\n    <li><span style=\"color: rgb(0,51,102)\"><strong>Indicative timetable for evaluation and grant agreement</strong></span></li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic: </span></strong><br />\r\n    <br />\r\n    <u>Research and Innovation Action:</u><br />\r\n    <br />\r\n    IMI2 Research and Innovation Action (IMI2-RIA) and (IMI2-IA):<br />\r\n    <br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guide-appl/jti/h2020-guide-pse-imi-ju_en.pdf\">Summary of the most relevant provisions for participatin in IMI2 actions</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_ptef/pt/h2020-call-pt-imi2-ria_en.pdf\">Standard proposal template</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_ptef/ef/h2020-call-ef-imi2-ria_en.pdf\">Standard evaluation form</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/mga/jti/h2020-mga-imi_en.pdf\">Annotated Model Grant Agreement</a><br />\r\n    <br />\r\n    &nbsp;</li>\r\n</ol>", "supportInfo": "<p>&nbsp;</p>\r\n<ul>\r\n    <li>Contact the <strong>IMI Programme Office</strong>. E-mail: <a href=\"mailto:Infodesk@imi.europa.eu\">Infodesk@imi.europa.eu</a>. Tel.: +32 2 221 8181</li>\r\n    <li>Contact the <a href=\"mailto:sofia@imi.europa.eu\">SOFIA IT helpdesk </a>for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.</li>\r\n    <li><a href=\"http://www.imi.europa.eu/content/states-representatives-groups\">IMI States Representative Group (SRG) </a>&ndash; contact your SRG member for assistance</li>\r\n    <li><a href=\"http://www.imi.europa.eu/content/partner-search\">IMI Partner Search Tool </a>- find a partner organisation for your proposal</li>\r\n    <li><a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/support/national_contact_points.html\">National Contact Points (NCP)</a> &ndash; contact your NCP for further assistance</li>\r\n    <li><a href=\"http://een.ec.europa.eu/\">Enterprise Europe Network </a>&ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding</li>\r\n    <li><a href=\"http://ec.europa.eu/research/index.cfm?lg=en&amp;pg=enquiries\">Research Enquiry Service </a>&ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular</li>\r\n    <li><strong>Ethics </strong>&ndash; to ensure compliance with ethical issues, check the information available on the <a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm\">Participant Portal</a>, on the <a href=\"http://ec.europa.eu/research/swafs/index.cfm?pg=policy&amp;lib=ethics\">Science and Society Portal </a>and in <a href=\"http://ec.europa.eu/euraxess/pdf/brochure_rights/am509774CEE_EN_E4.pdf\">The European Charter for Researchers and the Code of Conduct for their recruitment </a></li>\r\n    <li><a href=\"http://www.cencenelec.eu/research/pages/default.aspx\">CEN </a>and <a href=\"http://www.cenelec.eu/aboutcenelec/whatwestandfor/fosterinnovation/randd.html\">CENELEC</a>, the European Standards Organisations, <strong>advise you how to tackle standardisation in your project proposal</strong>. Contact the CEN-CENELEC Research Helpdesk at <a href=\"mailto:research@cencenelec.eu\">research@cencenelec.eu </a></li>\r\n</ul>\r\n<p><br />\r\n.</p>", "sepTemplate": "<p>To access the Electronic Submission Service of the topic, please select the <strong>type of action</strong> that is most relevant to your proposal from the list below and click on the <strong>'Start Submission' </strong>button. You will then be asked to confirm your choice of the type of action, the topic for the call, as these cannot be changed subsequently in the submission system. Upon confirmation you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Participant Portal and select the My Proposals page of the My Area section.</p>", "links": [{"callIdentifier": "H2020-JTI-IMI2-2015-05-two-stage-Master-1", "status": "Closed", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "IMI2-RIA", "criterionDescription": "Research and Innovation action", "url": "https://sofia.imi.europa.eu/Pages/Default.aspx", "startDate": "Jul 9, 2015 11:00:00 AM"}], "additionalDossiers": [], "infoPackDossiers": [{"callId": 6803, "id": 9297, "title": "IMI2 Call 5 topics text", "sectionId": 6803, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 507719, "docPath": "http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-05-03/1662621-c5_imi2_c5_text_9_july_2015_en.pdf", "id": 1662621, "fileName": "C5_IMI2_C5_TEXT_9 JULY 2015_EN.pdf", "common": false, "crc32": 3363543276}]}, {"callId": 6803, "id": 9292, "title": "IMI2 RIA-IA Evaluation Form ", "sectionId": 6803, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 97244, "docPath": "http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-05-03/1662622-c5_evaluation-form_ria-ia_en.pdf", "id": 1662622, "fileName": "C5_Evaluation-Form_RIA-IA_EN.pdf", "common": false, "crc32": 4124235812}]}, {"callId": 6803, "id": 9282, "title": "IMI2 RIA-IA Proposal Template", "sectionId": 6803, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 184629, "docPath": "http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-05-03/1662623-c5_proposal-template_ria-ia_en.pdf", "id": 1662623, "fileName": "C5_Proposal-Template_RIA-IA_EN.pdf", "common": false, "crc32": 3554732561}]}, {"callId": 6803, "id": 9277, "title": "IMI2 Manual for Submission, Evaluation and Grant Award", "sectionId": 6803, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 546419, "docPath": "http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-05-03/1662624-c5_manual_for_subission-evaluation_and_grant_award_en.pdf", "id": 1662624, "fileName": "C5_MANUAL FOR SUBISSION-EVALUATION AND GRANT AWARD_EN.pdf", "common": false, "crc32": 1572805413}]}, {"callId": 6803, "id": 9272, "title": "Summary of the most relevant provisions for participating in IMI2 actions", "sectionId": 6803, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 177193, "docPath": "http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-05-03/1662625-c5_summary_of_the_most_relevant_provisions_for_participating_in_imi2_actions_en.pdf", "id": 1662625, "fileName": "C5_Summary of the most relevant provisions for participating in IMI2 actions_EN.pdf", "common": false, "crc32": 1929684055}]}, {"callId": 6803, "id": 9287, "title": "IMI2 Model Grant Agreement", "sectionId": 6803, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 1209392, "docPath": "http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-05-03/1662626-c5_imi2_model_grand_agreement_en.pdf", "id": 1662626, "fileName": "C5_IMI2 MODEL GRAND AGREEMENT_EN.pdf", "common": false, "crc32": 1198578495}]}], "callDetailsJSONItem": {"additionalInfo": "<p>For full information on this call, please refer to the <a href=\"http://www.imi.europa.eu/content/imi-2-call-5-0\">Call&nbsp;5 section of the IMI website</a>.</p>\r\n<p>Please note that submitting short proposals for this call can only be done through the <a href=\"https://sofia.imi.europa.eu/Pages/Login.aspx?ReturnUrl=%2fPages%2fDefault.aspx\">IMI SOFIA software tool</a></p>", "latestInfos": [{"approvalDate": "Sep 23, 2015 11:02:51 AM", "lastChangeDate": "Sep 23, 2015 11:02:24 AM", "content": "<p><span style=\"color: #ff0000\">Update!</span> The European Medicines Agency (EMA) is willing to join the selected applicant consortium for the full proposal submission (stage two) of the topic 'Patient perspective elicitation on benefits and risks of medicinal products, from development through the entire life cycle, to inform the decision-making process by regulators and health technology assessment bodies' together with the industry consortium. The proposed EMA contribution can be found here (and on the IMI web site) for consideration by the applicant consortia. The EMA will cover its own participation costs. For more information please contact the IMI Infodesk (infodesk@imi.europa.eu) and/or the EMA (henry.fitt@ema.europa.eu).<br />\r\n&nbsp;</p>"}, {"approvalDate": "Jul 10, 2015 7:07:58 PM", "lastChangeDate": "Jul 10, 2015 7:07:58 PM", "content": "The submission session is now available for: H2020-JTI-IMI2-2015-05-01(IMI2-RIA), H2020-JTI-IMI2-2015-05-02(IMI2-RIA), H2020-JTI-IMI2-2015-05-03(IMI2-RIA), H2020-JTI-IMI2-2015-05-04(IMI2-RIA), H2020-JTI-IMI2-2015-05-05(IMI2-RIA), H2020-JTI-IMI2-2015-05-06(IMI2-RIA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}